User:Rithish Nimmagadda: Difference between revisions
Jump to navigation
Jump to search
| (12 intermediate revisions by the same user not shown) | |||
| Line 22: | Line 22: | ||
==Pages Authored/Co-authored/Collaborated== | ==Pages Authored/Co-authored/Collaborated== | ||
<div style="-moz-column-count:8; column-count: | <div style="-moz-column-count:8; column-count:2;"> | ||
#[[Epcoritamab-bysp]] | #[[Epcoritamab-bysp]] | ||
#[[Elfabrio]] | #[[Elfabrio]] | ||
#[[Mirikizumab-mrkz]] | #[[Mirikizumab-mrkz]] | ||
#[[Bimekizumab]] | |||
#[[Lotilaner]] | |||
#[[Quizartinib]] | |||
#[[Ritlecitinib]] | |||
#[[Tofersen]] | |||
#[[Retifanlimab-dlwr]] | |||
#[[Velmanase alfa-tycv]] | |||
#[[Elacestrant]] | |||
#[[Pirtobrutinib]] | |||
#[[vonoprazan, amoxicillin, and clarithromycin]] | |||
Latest revision as of 21:58, 21 May 2024
<nowiki>
Your Name
Rithish Nimmagadda,MBBS
Research scholar
Contact:945-278-1660
Email: rithishnvs@gmail.com [1]
Current Position
- research scholar (list chapters here)
Education
Medical Degree from Kamineni Academy of Medical sciences and research centre , Hyderabad , India